| 4759 |
Centers for Disease Control and Prevention |
Html |
en |
Spontaneous diffusion of an effective skin cancer prevention program through Web-based access to program materials . |
null |
| skin cancer | 0.485819 |
| cancer prevention program | 0.500106 |
| pool cool diffusion | 0.609089 |
| program materials online | 0.517712 |
| program | 0.773459 |
| Cool e-mail address | 0.571047 |
| active dissemination efforts | 0.547389 |
| outdoor pools | 0.488041 |
| Cool Web site | 0.550486 |
| private swimming pools | 0.488453 |
| nonstudy pools | 0.626912 |
| respondents | 0.513404 |
| sun safety | 0.590919 |
| Cool Diffusion Trial | 0.551812 |
| Pool Cool Web | 0.576108 |
| Web site | 0.671553 |
| program implementation | 0.540083 |
| spontaneous diffusion e-mails | 0.502024 |
| cool diffusion study | 0.538968 |
| Pool Cool | 0.965858 |
| program diffusion | 0.549174 |
| core program materials | 0.508646 |
| Web registrants | 0.553828 |
| Pool Cool program | 0.66806 |
| user-friendly program materials | 0.5246 |
|
| Web-based program materials | 0.612142 |
| Cool Web-based materials | 0.504497 |
| Web-based materials | 0.570749 |
| Pool Cool intervention | 0.490516 |
| Web-based sun-safety program | 0.490026 |
| program users | 0.532918 |
| various program materials | 0.505057 |
| larger outdoor pools | 0.480296 |
| public pool | 0.487941 |
| official Pool Cool | 0.574968 |
| Pool Cool e-mail | 0.58863 |
| spontaneous diffusion | 0.745523 |
| educational sun-safety program | 0.494352 |
| Pool Cool materials | 0.633065 |
| frequently used materials | 0.487637 |
| program materials | 0.768429 |
| diffusion study pools | 0.644272 |
| aluminum sun-safety signs | 0.530876 |
| additional program materials | 0.510466 |
| Pool Cool research | 0.498767 |
| connects program users | 0.487536 |
| general program information | 0.485465 |
| outdoor swimming pools | 0.495794 |
| potential program users | 0.52049 |
|
CLICK HERE |
| 4842 |
Centers for Disease Control and Prevention |
Html |
en |
In-Depth Information - Anaplasmosis |
Anaplasmosis is a tickborne disease caused by the bacterium Anaplasma phagocytophilum. It was previously known as human granulocytic ehrlichiosis (HGE) and has more recently been called human granulocytic anaplasmosis (HGA).
|
| suspect anaplasmosis case | 0.621833 |
| general public | 0.414747 |
| contact your state | 0.398218 |
| rickettsial diseases | 0.781855 |
| *Case definitions | 0.415055 |
| pages | 0.31797 |
| Mountain Spotted Fever | 0.514815 |
| routine electronic reporting | 0.493327 |
| CDC Infectious Disease | 0.578531 |
| CDC Case Report | 0.77422 |
| publication | 0.320459 |
| probable cases | 0.412065 |
| CDC policy | 0.509783 |
| CDC scientist | 0.52959 |
| laboratory consultation | 0.393922 |
| additional information | 0.408518 |
| U.S. healthcare providers | 0.484275 |
| diagnostic testing | 0.406143 |
| 1-800-CDC-INFO | 0.317672 |
| diagnosis | 0.356899 |
| version | 0.317996 |
| CRF | 0.355124 |
| detailed information | 0.422813 |
| anaplasmosis | 0.658917 |
| Private citizens | 0.402393 |
|
| healthcare providers | 0.670945 |
| treatment | 0.320482 |
| United States | 0.415534 |
| Non-U.S. healthcare providers | 0.473528 |
| National Notifiable Disease | 0.500185 |
| epidemiologic | 0.321141 |
| different state-specific form | 0.500849 |
| additional important information | 0.496487 |
| general questions | 0.484593 |
| PDF | 0.317983 |
| state health department | 0.969483 |
| patient | 0.318339 |
| Tickborne Rickettsial Diseases | 0.763493 |
| Ehrlichioses | 0.330252 |
| lieu | 0.324129 |
| Case Report Form | 0.657788 |
| business | 0.349552 |
| suspect ehrlichiosis case | 0.492923 |
| certain tests | 0.394125 |
| RMSF | 0.320078 |
| specimens | 0.403694 |
| specimen submission | 0.609575 |
| advance approval | 0.396018 |
| management | 0.336853 |
|
CLICK HERE |
| 7590 |
Centers for Disease Control and Prevention |
Html |
en |
TB Fact Sheets - Interferon-Gamma Release Assays (IGRAs) |
null |
| low risk | 0.278419 |
| TB disease | 0.404361 |
| white blood cells | 0.292969 |
| fresh blood samples | 0.206152 |
| positive test result | 0.241197 |
| Interferon Gamma Release | 0.278136 |
| infection increases | 0.25607 |
| tuberculosis disease | 0.283209 |
| Detect Mycobacterium tuberculosis | 0.369735 |
| IGRAs | 0.25799 |
| test results | 0.262893 |
| test | 0.302518 |
| standard qualitative test | 0.214706 |
| IGRA testing | 0.203541 |
|
| tuberculin skin tests | 0.200634 |
| Interferon-Gamma Release Assays | 0.222012 |
| mycobacterium tuberculosis infection | 0.572165 |
| borderline test result | 0.233684 |
| positive TST | 0.223583 |
| M. tuberculosis | 0.908847 |
| Gamma Release Assays | 0.276782 |
| initial IGRA result | 0.243075 |
| viable blood cells | 0.203436 |
| IGRA test results | 0.246879 |
| IGRA test result | 0.287448 |
| TST | 0.230247 |
| latent tuberculosis infection | 0.42121 |
| M. tuberculosis infection | 0.800883 |
|
CLICK HERE |
| 11457 |
Centers for Disease Control and Prevention |
Html |
en |
Chronic Disease Prevention & Health Promotion |
Heart disease, stroke, cancer, diabetes, and other chronic diseases cause 7 in 10 deaths every year in the U.S. CDC works to prevent the risk factors that cause these diseases, such as tobacco use, obesity, physical inactivity, poor nutrition, and alcohol abuse. |
| smoking-related disease | 0.71493 |
| obesity rates | 0.718108 |
| disability | 0.533676 |
| U.S. CDC | 0.761023 |
| tips | 0.551654 |
| poor nutrition | 0.715595 |
| adult asthma | 0.680664 |
| heart disease-causing chemicals | 0.879521 |
| early detection | 0.692506 |
| health conditions | 0.677792 |
| U.S. territories | 0.701716 |
| deaths | 0.586887 |
| generation | 0.533197 |
| risk factors | 0.711712 |
| tobacco smoke | 0.746309 |
| lives | 0.53373 |
| alcohol abuse | 0.712685 |
| Chronic disease prevention | 0.907969 |
| Smokers campaign | 0.793628 |
| Americans | 0.567023 |
| organizations—a program | 0.697407 |
| cervical cancers | 0.717619 |
| low-income preschoolers | 0.719788 |
| heart surgery scars | 0.851476 |
| millions | 0.53533 |
|
| page | 0.538016 |
| unnecessary healthcare costs | 0.880016 |
| real former smokers | 0.791533 |
| obstructive pulmonary disease | 0.853681 |
| tens | 0.540073 |
| smoke-free workplaces | 0.716578 |
| cervical cancer screenings | 0.879725 |
| states | 0.533089 |
| PDF | 0.537992 |
| public places | 0.695297 |
| 2M | 0.553506 |
| billions | 0.548078 |
| chronic diseases | 0.740659 |
| daily smokers | 0.7924 |
| diabetes-related complications | 0.699128 |
| hard-hitting campaign features | 0.863722 |
| Diabetes Prevention Program | 0.882589 |
| throat surgeries | 0.693174 |
| tobacco education campaign | 0.905155 |
| limb amputations | 0.711315 |
| time | 0.533229 |
| future health problems | 0.869023 |
| breast | 0.555122 |
| physical inactivity | 0.737135 |
|
CLICK HERE |
| 11507 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | DBD Bulletin Fall 2011 | Publications | Bacterial Div | CDC |
Division of Bacterial Diseases Bulletin Fall |
| pneumococcal conjugate vaccines | 0.606795 |
| new vaccines | 0.55697 |
| diphtheria toxoid | 0.558692 |
| R. Accelerating introduction | 0.597134 |
| Shah SS | 0.557086 |
| historical purposes | 0.559238 |
| multi-target real-time PCR | 0.590285 |
| CDC. Legionellosis | 0.563619 |
| PLoS ONE. | 0.561937 |
| Chien YW | 0.558318 |
| nonsusceptible Streptococcus pneumoniae | 0.598922 |
| public health surveillance | 0.589366 |
| Griffin MR. Assessing | 0.59447 |
| Infectious Diseases Society | 0.683009 |
| tetanus toxoid | 0.558203 |
| historical reasons | 0.558163 |
| reference serum | 0.55451 |
| Lancet Infect Dis. | 0.62938 |
| Bradley JS | 0.557225 |
| childhood pneumonia | 0.551509 |
| early-onset neonatal sepsis | 0.59511 |
| acellular pertussis vaccine | 0.627803 |
| Neisseria meningitidis | 0.59549 |
| Clin Infect Dis. | 0.755484 |
| clinical practice guidelines | 0.608771 |
|
| Plikaytis BD | 0.554836 |
| CDC. FDA approval | 0.601693 |
| routinely collected surveillance | 0.598203 |
| Clin Microbiol | 0.588133 |
| type b vaccine | 0.568922 |
| recent Haemophilus influenzae | 0.606516 |
| Byington CL | 0.564269 |
| United States | 0.70749 |
| comparative genomics database | 0.589094 |
| age indication | 0.556687 |
| invasive pneumococcal disease | 0.594723 |
| CDC. Office-related | 0.563075 |
| Dis J. Epub | 0.627807 |
| Grijalva CG | 0.558461 |
| Neisseria Base | 0.578229 |
| Pediatric Infectious Diseases | 0.606407 |
| human pneumococcal standard | 0.601014 |
| community-acquired pneumonia | 0.573991 |
| Lond B Biol | 0.555533 |
| Philos Trans | 0.555234 |
| Clin Vaccine Immunol. | 0.652804 |
| et al | 0.946904 |
| Taylor TH Jr | 0.596341 |
| PLoS Med. | 0.559823 |
|
CLICK HERE |
| 11668 |
Centers for Disease Control and Prevention |
Html |
en |
Ebola Virus Disease Outbreak - West Africa, September2014 |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| ongoing outbreak | 0.309226 |
| country | 0.208147 |
| Guinea | 0.299994 |
| Sierra Leone | 0.947134 |
| Ebola Epidemiology Team | 0.642775 |
| Special Pathogens Branch | 0.432553 |
| West Africa countries | 0.417836 |
| actual cases | 0.287578 |
| Ebola cases | 0.60104 |
| MMWR website | 0.289856 |
| Situational Awareness Team | 0.391001 |
| Ebola outbreak | 0.609271 |
| MMWR Early Release | 0.450638 |
| CDC response teams | 0.475596 |
| Disease Control | 0.249567 |
| case counts | 0.440687 |
| Barbara Knust | 0.299048 |
| Zoonotic Infectious Diseases | 0.434955 |
|
| National Center | 0.277849 |
| World Health Organization | 0.673474 |
| health situation | 0.28823 |
| up-to-date clinical guidelines | 0.381296 |
| highest cumulative incidence | 0.425494 |
| Total case | 0.279023 |
| Geospatial Research | 0.259635 |
| latest updates | 0.255537 |
| Public Health Preparedness | 0.399806 |
| Liberia | 0.377899 |
| Corresponding author | 0.279753 |
| Geographic distribution | 0.41715 |
| unknown proportion | 0.273704 |
| Services Program | 0.257261 |
| West Africa | 0.759469 |
| Nigeria Center | 0.295254 |
| recent case | 0.26812 |
| Ebola virus disease | 0.625349 |
|
CLICK HERE |
| 11772 |
Centers for Disease Control and Prevention |
Html |
en |
Updates on CDC's Polio Eradication Efforts - October 3, 2014 |
Polio is a crippling and potentially deadly infectious disease caused by a virus that spreads from person to person invading the brain and spinal cord and causing paralysis. CDC is a strategic partner in the overall effort to eradicate polio worldwide. |
| global polio eradication | 0.811749 |
| polio eradication plans | 0.483855 |
| polio eradication | 0.97225 |
| Polio incidence | 0.334596 |
| polio outbreaks | 0.402834 |
| Polio Eradication Effort | 0.54426 |
| CDC’s Emergency | 0.232233 |
| polio vaccination | 0.398285 |
| South East Asia | 0.238741 |
| polio eradication activities | 0.585048 |
| CDC Director Thomas | 0.27452 |
| CDC resources | 0.220571 |
| polio worldwide | 0.363959 |
| EOC operational structure | 0.231371 |
| CDC immunization staff | 0.24486 |
|
| polio vaccination campaigns | 0.390624 |
| CDC’s engagement | 0.213828 |
| global polio surveillance | 0.387023 |
| entire CDC community | 0.260958 |
| Polio Eradication Initiative | 0.535714 |
| World Health Organization | 0.34746 |
| Syrian Arab Republic | 0.263611 |
| polio eradication progress | 0.478694 |
| polio cases | 0.40001 |
| CDC’s EOC | 0.262296 |
| polio vaccination campaign | 0.384553 |
| CDC’s polio | 0.427885 |
| CDC polio eradication | 0.65139 |
| polio surveillance | 0.44782 |
| Dr. Frieden | 0.255987 |
|
CLICK HERE |
| 12372 |
Centers for Disease Control and Prevention |
Image |
null |
Know: Your Risk (BRCA) (612W x 612H) |
null |
|
|
CLICK HERE |
| 13231 |
Centers for Disease Control and Prevention |
Html |
en |
Preliminary Incidence and Trends of Infection with PathogensTransmitted Commonly Through Food - Foodborne Diseases ActiveSurveillance Network, 10 U.S. Sites, 2006-2014 |
Stacy M. Crim, MPH1, Patricia M. Griffin, MD1, Robert Tauxe, MD1, Ellyn P. |
| overall incidence | 0.581915 |
| Salmonella serotypes | 0.613826 |
| Salmonella serotype Infantis | 0.698396 |
| STEC non-O157 infections | 0.6439 |
| Salmonella serotype Typhimurium | 0.674025 |
| serotype Infantis infections | 0.613008 |
| infections | 0.749664 |
| Zoonotic Infectious Diseases | 0.466252 |
| Salmonella serotype Javiana | 0.488817 |
| serotype Typhimurium infections | 0.703909 |
| laboratory-confirmed infections | 0.549564 |
| non-O157 STEC infections | 0.688858 |
| unchanged overall incidence | 0.509739 |
| ongoing food safety | 0.437809 |
| Salmonella serotype | 0.755654 |
| Foodborne Diseases Active | 0.523358 |
| key foodborne pathogens | 0.520687 |
| laboratory-confirmed parasitic infections | 0.507321 |
| STEC O157 infection | 0.600285 |
| Olga L. Henao | 0.501547 |
| culture-independent diagnostic tests | 0.70736 |
| specimen collection | 0.440157 |
| STEC non-O157 | 0.911432 |
| commonly identified Salmonella | 0.490904 |
| food safety efforts | 0.510674 |
|
| ground beef | 0.460028 |
| hemolytic uremic syndrome | 0.808058 |
| culture-independent diagnostic test | 0.503233 |
| Infections Program | 0.440752 |
| national health objectives | 0.436007 |
| culture-confirmed infections | 0.487879 |
| STEC O157 infections | 0.668646 |
| public health | 0.601967 |
| Salmonella serotypes Infantis | 0.532727 |
| Campylobacter | 0.466517 |
| STEC reports | 0.526466 |
| Incidence calculations | 0.486971 |
| Salmonella serotypes Javiana | 0.495366 |
| serotype Infantis infection | 0.440389 |
| food safety | 0.647305 |
| Salmonella enterica serotype | 0.529943 |
| Preliminary Incidence | 0.508269 |
| culture-confirmed bacterial infections | 0.504077 |
| Salmonella Typhimurium infections | 0.640217 |
| STEC O157 | 0.982534 |
| Diseases Active Surveillance | 0.503027 |
| incidence | 0.890341 |
| Active Surveillance Network | 0.498992 |
| Vibrio | 0.45039 |
|
CLICK HERE |
| 13620 |
Centers for Disease Control and Prevention |
Html |
en |
When Caring for Suspect or Confirmed Patients with Ebola |
What SHOULD be done for a patient under investigation (PUI) for Ebola virus disease? |
| healthcare personnel | 0.576665 |
| door | 0.430126 |
| current temperature ≥100.4°F | 0.738551 |
| inform | 0.480875 |
| log | 0.429945 |
| criteria | 0.438027 |
| appropriate staff | 0.567013 |
| fever | 0.437536 |
| public health authorities | 0.925115 |
| standard precautions | 0.626826 |
| alternative diagnoses | 0.593544 |
| patient | 0.570599 |
| procedures | 0.429073 |
| infection control program | 0.704209 |
|
| bedside commode | 0.600016 |
| waste | 0.428054 |
| necessary tests | 0.577537 |
| private bathroom | 0.575117 |
| CDC guidelines | 0.576243 |
| private room | 0.565385 |
| concerns | 0.436196 |
| local public health | 0.88713 |
| home | 0.43101 |
| symptoms | 0.430454 |
| EVD | 0.459746 |
| exposure | 0.435464 |
| Contact your state | 0.549987 |
| health department numbers | 0.695178 |
|
CLICK HERE |